On June 23, China Life Insurance fell 3.17% in regular trading, trading at HK$29.28/share, with turnover of HK$511 million.

On the news front, Goldman Sachs recently issued a research report assigning China Life a Neutral rating with a 12-month target price of HK$28.5, below the current stock price, corresponding to 1.0x projected 2027 price-to-book ratio. Additionally, financial regulators in Yunnan and Anhui provinces issued administrative penalties against multiple China Life subsidiaries for violations including fabricating business documents, failing to accurately record sales agent information, and claims processing delays, with fines totaling over RMB 1 million across entities and individuals. Compliance risks continue to weigh on sentiment.

The broader insurance sector remained under pressure, with New China Life down 3.86%, China Taiping down 2.50%, Ping An down 1.82%, and AIA down 1.95%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)